相关实验视频

Updated: Jul 21, 2025

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues

Published on: June 3, 2016

在单细胞分化过程中,Ezh2作为表观遗传检查点调节器出现,限制心脏功能障碍后的MI

Julie Rondeaux¹, Déborah Groussard¹, Sylvanie Renet¹

¹Univ Rouen Normandie, Inserm EnVI UMR 1096, F-76000, Rouen, France.

Nature communications

|July 25, 2023

概括

在雌性小鼠中,药物抑制EZH2通过增强M2巨细胞功能和加速炎症解消,促进心肌梗塞 (MI) 后的心脏修复.

科学领域:

免疫学免疫学免疫学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
心血管生物学心血管生物学

背景情况:

基斯H3K27甲基化对于M2巨分离和心肌梗塞 (MI) 后的心脏修复至关重要.
EZH2 (Enhancer of zeste homolog 2) 是负责H3K27甲基化的酶,可能调节这个过程.

研究的目的:

调查EZH2在M2巨细胞两极化和心脏中风后心脏修复中的作用.
在MI的小鼠模型中评估药物EZH2抑制的治疗潜力.

主要方法:

在试验室中将单细胞分化为M2巨细胞.
在体内研究使用MI的小鼠模型.
使用GSK-343.3进行EZH2的药理抑制.
评估巨细胞两极分化,心脏修复和心脏功能.

主要成果:

在M2巨分化期间和MI后心脏巨中,EZH2表现出宫外和不活跃的细胞质局部化.
用GSK-343的药理EZH2抑制解决了H3K27甲基化,增强了M2巨细胞修复功能,并加速了心脏炎症的解决.
在女性小鼠中,GSK-343治疗减少了心脏病发作扩张,并改善了心脏功能.

结论:

EZH2在M2巨细胞极化中起到表观遗传检查点调节者的作用.
心脏免疫细胞的药理表观遗传调节为限制心脏中风后不良心脏重塑提供了一个有前途的治疗策略.

更多相关视频

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...